These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16049602)

  • 1. Moxonidine suitable for hypertensive menopausal women with metabolic syndrome.
    Cardiovasc J S Afr; 2005; 16(3):186. PubMed ID: 16049602
    [No Abstract]   [Full Text] [Related]  

  • 2. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of moxonidine in patients with essential hypertension combined with metabolic syndrome].
    Syrtlanova ER; Gil'mutdinova LT
    Kardiologiia; 2003; 43(3):33-5. PubMed ID: 12913980
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 7. Rare psychotropic adverse event of moxonidine.
    Fuckar K; Lakusić N; Cerovec D
    Psychiatr Danub; 2009 Dec; 21(4):518. PubMed ID: 19935487
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist.
    Kaaja R; Manhem K; Tuomilehto J
    Int J Clin Pract Suppl; 2004 Mar; (139):26-32. PubMed ID: 15117110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome in women: implications for therapy.
    Rosano GM; Vitale C; Silvestri A; Fini M
    Int J Clin Pract Suppl; 2004 Mar; (139):20-5. PubMed ID: 15117109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 13. Moxonidine well tolerated and effective in the treatment of viscerally obese, non-controlled hypertensive patients.
    Cardiovasc J S Afr; 2006; 17(4):209. PubMed ID: 17001427
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.
    Schachter M; Mitchell G; Niziol C; Abhyankar BA
    Int J Clin Pract; 2003; 57(6):479-82. PubMed ID: 12918886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients.
    Kirch W; Hutt HJ; Plänitz V
    J Clin Pharmacol; 1990 Dec; 30(12):1088-95. PubMed ID: 2273081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
    Geriatr Gerontol Int; 2010 Jan; 10(1):70-7. PubMed ID: 20102385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive treatment in patients with metabolic syndrome.
    Siegel D; Swislocki AL
    Metab Syndr Relat Disord; 2010 Apr; 8(2):95-104. PubMed ID: 20156078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Moxonidine. A new centrally active antihypertensive drug].
    Schrader J; Molderings GJ; Dominiak P
    Internist (Berl); 1992 Oct; 33(10):704-6. PubMed ID: 1428688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.